Kaplitt MG - Search Results

1

In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector.

During MJ, Samulski RJ, Elsworth JD, Kaplitt MG, Leone P, Xiao X, Li J, Freese A, Taylor JR, Roth RH, Sladek JR Jr, O'Malley KL, Redmond DE Jr. During MJ, et al. Among authors: kaplitt mg. Gene Ther. 1998 Jun;5(6):820-7. doi: 10.1038/sj.gt.3300650. Gene Ther. 1998. PMID: 9747462

2

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.

Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ. Kaplitt MG, et al. Nat Genet. 1994 Oct;8(2):148-54. doi: 10.1038/ng1094-148. Nat Genet. 1994. PMID: 7842013

3

Prospects for gene therapy in Parkinson's disease.

Freese A, Stern M, Kaplitt MG, O'Connor WM, Abbey MV, O'Connor MJ, During MJ. Freese A, et al. Among authors: kaplitt mg. Mov Disord. 1996 Sep;11(5):469-88. doi: 10.1002/mds.870110502. Mov Disord. 1996. PMID: 8866488 Review.

4

Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector.

Kaplitt MG, Xiao X, Samulski RJ, Li J, Ojamaa K, Klein IL, Makimura H, Kaplitt MJ, Strumpf RK, Diethrich EB. Kaplitt MG, et al. Among authors: kaplitt mj. Ann Thorac Surg. 1996 Dec;62(6):1669-76. doi: 10.1016/s0003-4975(96)00946-0. Ann Thorac Surg. 1996. PMID: 8957370 Free article.

5

Transfection of human lactotroph adenoma cells with an adenovirus vector expressing tyrosine hydroxylase decreases prolactin release.

Freese A, During MJ, Davidson BL, Gennarelli TA, Kaplitt MG, Flamm ES, Snyder PJ. Freese A, et al. Among authors: kaplitt mg. J Clin Endocrinol Metab. 1996 Jun;81(6):2401-4. doi: 10.1210/jcem.81.6.8964885. J Clin Endocrinol Metab. 1996. PMID: 8964885

6

Adenovirus vector-mediated gene transfer into human epileptogenic brain slices: prospects for gene therapy in epilepsy.

O'Connor WM, Davidson BL, Kaplitt MG, Abbey MV, During MJ, Leone P, Langer D, O'Connor MJ, Freese A. O'Connor WM, et al. Among authors: kaplitt mg. Exp Neurol. 1997 Nov;148(1):167-78. doi: 10.1006/exnr.1997.6658. Exp Neurol. 1997. PMID: 9398459 Free article.

7

Direct gene transfer into human epileptogenic hippocampal tissue with an adeno-associated virus vector: implications for a gene therapy approach to epilepsy.

Freese A, Kaplitt MG, O'Connor WM, Abbey M, Langer D, Leone P, O'Connor MJ, During MJ. Freese A, et al. Among authors: kaplitt mg. Epilepsia. 1997 Jul;38(7):759-66. doi: 10.1111/j.1528-1157.1997.tb01462.x. Epilepsia. 1997. PMID: 9579902 Free article.

8

Prospects for gene therapy in pediatric neurosurgery.

Kaplitt MG, Darakchiev B, During MJ. Kaplitt MG, et al. Pediatr Neurosurg. 1998 Jan;28(1):3-14. doi: 10.1159/000028611. Pediatr Neurosurg. 1998. PMID: 9693323 Review.

9

Peroral gene therapy of lactose intolerance using an adeno-associated virus vector.

During MJ, Xu R, Young D, Kaplitt MG, Sherwin RS, Leone P. During MJ, et al. Among authors: kaplitt mg. Nat Med. 1998 Oct;4(10):1131-5. doi: 10.1038/2625. Nat Med. 1998. PMID: 9771745

10

Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.

During MJ, Kaplitt MG, Stern MB, Eidelberg D. During MJ, et al. Among authors: kaplitt mg. Hum Gene Ther. 2001 Aug 10;12(12):1589-91. Hum Gene Ther. 2001. PMID: 11529246 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters